drugset / Trial / NCT02678195

3 Days Versus 5 Days Amoxicillin for Chest-indrawing Childhood Pneumonia in Malawi

NCT02678195 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This clinical trial evaluates the duration of treatment of chest-indrawing pneumonia in children. Half the children will receive 3 days of amoxicillin dispersible tablets (DT) and then 2 days of placebo, while the other half will receive 5 days of amoxicillin DT.

Timeline

Start
2016-03
Primary completion
2019-04
Completion
2019-12

Outcome

Met primary endpoint

paper In HIV-uninfected Malawian children, treatment with amoxicillin for chest-indrawing pneumonia for 3 days was noninferior to treatment for 5 days. PMID 32609979 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 500 mg Oral
Subject Amoxicillin Other / unclassified 1000 mg Oral
Subject Amoxicillin Other / unclassified 1500 mg Oral

Indications